Risk of urinary adverse effects of bevacizumab therapy in patients with ovarian cancer: a systematic review and meta-analysis. Archivio Italiano di Urologia e Andrologia, [S. l.], v. 97, n. 4, 2025. DOI: 10.4081/aiua.2025.14659. Disponível em: https://www.pagepressjournals.org/aiua/article/view/14659. Acesso em: 30 jul. 2026.